Institutional Core Labs
- iLabs
- Bioanalytics & Single-Cell
- Biospecimen and Translational Genomics
- Flow Cytometry
- Mass Spectometry
- Optical Imaging
- Structural Biology (NMR)
- Structural Biology (X-Ray Crystallography)
Find a Researcher
Research by School
Software Training & Cyberinfrastructure
Additional Resources
Fueling Research by the Numbers
Researchers at UT Health San Antonio contribute to leading publications in numerous fields of specialty and continually compete with institutions nationwide for grants to support research with the potential for high-impact discoveries. UT Health San Antonio is ranked 41 among healthcare institutions worldwide by Nature Index. Learn more about Nature Index
-
356
Faculty with Extramural Grants in 2021
-
-
$143.9M
Organized research awards in FY 2020
“Cold-stored whole blood is an FDA licensed and American Association of Blood Bankers approved blood product. I never imagined it would have such an impact. If we can save one life, that would be fantastic and that’s what we’re after.”
-Donald Jenkins, M.D.
Betty and Bob Kelso Distinguished Chair
UT Health San Antonio
Associate Deputy Director, Military Health Institute
Researcher Spotlight
-
Microbiology
When the COVID-19 pandemic began, Evelien Bunnik, PhD, converted her lab from malaria research to study COVID-19 antibodies.
-
Population Health
Luz Garcini, PhD, MPH, Assistant Professor at the Center for Research to Advance Community Health (ReACH) focuses her research on identifying, understanding, and addressing the health needs of Latinx immigrant families.
-
Cardiovascular
Long before becoming the Chief of Cardiology at UT Health San Antonio, Dr. Allen Anderson's first job was working at his grandparent's chicken farm, where he developed an uncanny knack for identifying the best birds. In November, Anderson came to UT Health San Antonio from Northwestern University, where he was a nationally recognized leader in heart failure and cardiac transplantation.
-
Diabetes & Kidney Health
Carolina Solis-Herrera, M.D., Voelcker Fund Young Investigator, is studying mechanisms to explain cardiovascular benefits observed in high-risk type 2 diabetes patients treated with a class of medication called a SGLT2 inhibitor.
“In the last 18 months, we’ve recruited a dozen well-funded, high-impact scientists who are on the cutting edge of their fields. Just coming to work every day and being around brilliant people who are really hard-working and care deeply about their patients and their students is extremely rewarding.”
-Robert Hromas, M.D., FACP, dean of the Long School of Medicine as quoted in Future Magazine